跳至主要内容
临床试验/CTRI/2023/12/060657
CTRI/2023/12/060657尚未招募3 期

Effects of a multimodal 24-week yoga intervention in patients with non-alcoholic fatty liver disease (NAFLD) - A non-inferiority randomized clinical trial - NI

CCRYN- COLLABORATIVE CENTRE FOR MIND BODY INTERVENTION THROUGH YOGA #3012, Research block-B,0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • oNAFLD patients will be defined by the evidence of hepatic steatosis by Fibroscan with controlled attenuation parameter (CAP) >248 dB/m in the absence of significant alcohol intake ( >20 g/day irrespective of gender) or other concomitant etiologies of liver disease
  • oAll patients must be on stable doses of medical therapy for 6 weeks before the study start date.
  • oBe willing and able to participate in the full program
  • oBe willing and able to functionally participate in all activities set as part of the intervention
  • oBe able to complete all day-to-day activities and instrumental activities of daily living independently, completely without assistance from others
  • oAge eighteen years to sixty years

排除标准

  • oPatients with cirrhosis (LSM >13.6 kPa)
  • oAny patient on drugs causing change in steatosis including SGLT2 inhibitors,GLP1 agonists, Vitamin E, Saroglitazar, and thiazolidinediones
  • oPregnant, lactating women
  • oPatients who will not be able to carry out yoga and exercise protocol safely, recent fall or > 3 falls in a year, recent hospitalization in 1 month, and those who fail to give consent will be excluded
  • oSignificant alcoholic consumption ( >20 g/day irrespective of gender)
  • oCompeting etiology for hepatic steatosis like Hep C, Medications, parenteral nutrition, Wilson’s disease and severe malnutrition
  • oCoexisting causes for chronic liver disease (CLD) including hemochromatosis, autoimmune liver disease, chronic viral hepatitis, Wilsons Disease and drug induced liver injury
  • oThe patients with severe cardio-pulmonary disease, coronary artery disease, cardiomyopathy, severe musculoskeletal disease, neuropsychiatric disease, and history of cardiovascular accident.
  • oAny patient not meeting any part of the inclusion criteria

研究者

发起方
CCRYN- COLLABORATIVE CENTRE FOR MIND BODY INTERVENTION THROUGH YOGA #3012, Research block-B,

相似试验

Effect of yoga on non-alcoholic fatty liver disease... | 临床试验